What are Merit Medical Systems's profit margins?

Gross margin is 48.7% and operating margin is 12.2%, with a 9.0% net margin.

Where does Merit Medical Systems's income statement data come from?

Every line is extracted from Merit Medical Systems's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Merit Medical Systems MMSI Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Total revenue	$1.52B+11.8%	$1.36B+7.9%	$1.26B+9.2%	$1.15B+7.1%
Total cost of revenue	$777.64M+9.0%	$713.18M+5.9%	$673.49M+6.6%	$631.88M+7.2%
Gross profit	$738.27M+14.8%	$643.33M+10.2%	$583.87M+12.5%	$519.1M+7.0%
Gross margin	48.7%+1.3pp	47.4%+1.0pp	46.4%+1.3pp	45.1%-0.1pp
Research and development	$97.35M+11.3%	$87.47M+5.7%	$82.73M+9.6%	$75.51M+6.0%
Selling, general and administrative	$455.21M+13.9%	$399.73M+7.0%	$373.68M+9.1%	$342.53M+2.0%
Depreciation and amortization	$123.17M+19.9%	$102.71M+14.1%	$89.99M+10.0%	$81.8M-2.7%
Other operating expenses	$553.55M+13.5%	$487.64M+6.0%	$459.93M+6.6%	$431.54M+1.7%
Total operating expenses	$553.55M+13.5%	$487.64M+6.0%	$459.93M+6.6%	$431.54M+1.7%
Operating income	$184.72M+18.6%	$155.69M+25.6%	$123.94M+41.5%	$87.56M+43.7%
Operating margin	12.2%+0.7pp	11.5%+1.6pp	9.9%+2.2pp	7.6%+1.9pp
Interest expense	$26.46M-15.2%	$31.22M+101%	$15.51M+145%	$6.34M+20.5%
Interest income	$15.07M-42.5%	$26.23M+968%	$2.46M+459%	$439K-42.9%
Other income (expense), net	-$13.78M-142%	-$5.7M+51.9%	-$11.86M-140%	-$4.93M+29.5%
Income before income taxes	$170.94M+14.0%	$149.99M+33.8%	$112.09M+35.7%	$82.63M+53.3%
Income tax expense	$42.45M+43.2%	$29.64M+67.6%	$17.68M—	——
Net income	$128.49M+6.8%	$120.36M+27.5%	$94.41M+26.7%	$74.52M+53.8%
Net margin	8.5%-0.4pp	8.9%+1.4pp	7.5%+1.0pp	6.5%+2.0pp
Diluted earnings per share	$2.13+4.9%	$2.03+24.5%	$1.63+25.4%	$1.30+54.8%
Basic earnings per share	$2.17+4.8%	$2.07+26.2%	$1.64+25.2%	$1.31+52.3%
Weighted-average shares, diluted	242.3M+2.6%	236.2M+1.2%	233.4M+1.3%	230.4M+0.5%
Weighted-average shares, basic	236.4M+1.7%	232.5M+1.0%	230.2M+1.4%	226.9M+1.2%
Acquisition Of Developed Technology In Accrued Expenses	——	——	$3.71M—	——
Business Combination Contingent Consideration Arrangements Contingent Consideration Benefit	——	-$443K—	——	-$4.7M-41.5%
Capital investments accrued but not yet paid	——	$13.24M+60.2%	$8.27M—	——
Revenue recognized that was included in deferred income at the beginning of the period	$103K0.0%	$103K-1.0%	$104K-2.8%	$107K-0.9%
Gain/(loss) on dispositions, net	-$2.3M-54.5%	-$1.49M+74.5%	-$5.84M-1,436%	-$380K+70.8%
Gain on sale of business and assets	$249K—	——	$431K—	——
Goodwill And Intangible Asset Impairment	$313K-31.4%	$456K—	——	$2.28M—
Income Taxes Paid, Net	$31.39M-30.3%	$45.05M+42.9%	$31.53M+84.5%	$17.09M+93.6%
Increase (Decrease) in Accounts Payable, Trade	——	——	——	$12.66M—
Increase (Decrease) in Accounts Receivable	——	$13.69M—	——	$15.53M—
Increase Decrease In Accrued Income Taxes Payable	$5.61M—	——	——	$4.55M—
Accrued liabilities	$14.26M—	——	——	——
Increase (Decrease) in Income Taxes Receivable	-$246K—	——	——	-$1.95M—
Increase (Decrease) in Inventories	$21.6M—	——	——	$47.93M+90.3%
Short- and long-term operating lease liabilities	-$11.17M+8.3%	-$12.18M-6.0%	-$11.49M-3.3%	-$11.13M+10.3%
Increase (Decrease) in Other Operating Assets	$1.83M-69.8%	$6.07M—	——	——
Other liabilities	——	——	-$2.53M—	——
Increase (Decrease) in Other Receivables	——	$6.69M+375%	-$2.43M—	——
Increase (Decrease) in Prepaid Expense and Other Assets	——	——	——	——
Interest Paid, Excluding Capitalized Interest, Operating Activity	——	$23.24M+65.4%	$14.05M+125%	$6.26M+19.0%
Net interest and investment income (loss)	$15.07M-42.5%	$26.23M+968%	$2.46M+459%	$439K-42.9%
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation	$16.36M—	——	$613.82M+1,119%	-$60.26M+38.8%
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation	-$247.39M+32.9%	-$368.65M-110%	-$175.35M-205%	-$57.4M-54.5%
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation	$297.37M+34.7%	$220.8M+52.1%	$145.15M+27.0%	$114.29M-22.4%
Operating lease right-of-use assets amortization expense	$11.48M-4.5%	$12.02M+6.3%	$11.31M+8.8%	$10.39M-11.3%
Other income, net (Note 6)	-$2.39M-236%	-$711K-159%	$1.2M+24.1%	$967K+139%
Payment for Contingent Consideration Liability, Financing Activities	$2.69M+929%	$261K-92.7%	$3.57M-89.2%	$32.92M+209%
Payments to Acquire Businesses, Net of Cash Acquired	$144.77M-54.8%	$320.18M—	——	——
Payments to Acquire Intangible Assets	$3.12M+7.5%	$2.9M+20.4%	$2.41M-24.1%	$3.18M+12.0%
Payments to Acquire Property, Plant, and Equipment	$81.72M+133%	$35.14M+2.5%	$34.29M-23.8%	$45.03M+61.2%
Proceeds from Issuance of Common Stock	$28.21M-31.0%	$40.91M+163%	$15.58M-22.4%	$20.07M-5.8%
Research and development expense	$97.35M+11.3%	$87.47M+5.7%	$82.73M+9.6%	$75.51M+6.0%
Revenue From Contract With Customer Excluding Assessed Tax	$1.52B+11.8%	$1.36B+7.9%	$1.26B+9.2%	$1.15B+7.1%
Stock-based compensation	$43.46M+52.6%	$28.47M+33.5%	$21.33M+18.2%	$18.04M+12.1%
Stock Surrendered During Period Value Stock Options Exercised	——	——	——	——
EBIT	$184.72M+18.6%	$155.69M+25.6%	$123.94M+41.5%	$87.56M+43.7%
EBITDA	$307.89M+19.2%	$258.4M+20.8%	$213.93M+26.3%	$169.37M+16.8%
EBITDA	$307.89M+19.2%	$258.4M+20.8%	$213.93M+26.3%	$169.37M+16.8%
EBITDA margin	20.3%+1.3pp	19%+2.0pp	17%+2.3pp	14.7%+1.2pp
EBIT	$184.72M+18.6%	$155.69M+25.6%	$123.94M+41.5%	$87.56M+43.7%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Merit Medical Systems's profit margins?: Gross margin is 48.7% and operating margin is 12.2%, with a 9.0% net margin.
Where does Merit Medical Systems's income statement data come from?: Every line is extracted from Merit Medical Systems's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.